Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
9,315
Total Claims
$1.1M
Drug Cost
462
Beneficiaries
$2,306
Cost/Patient
Risk Score Breakdown 24/100
Score components are additive. Read full methodology
Peer Comparison vs. 106,889 Family Practice providers
-68%
Opioid rate vs peers
0.8% vs 2.6% avg
+116%
Cost per patient vs peers
$2,306 vs $1,068 avg
+60%
Brand preference vs peers
14.4% vs 9.0% avg
⚠️ Opioid + Benzodiazepine Co-Prescriber
This provider prescribes both opioids and benzodiazepines. The FDA has issued a Black Box Warning about the life-threatening risks of concurrent use.
Opioid Prescribing
0.8%
Opioid Rate
78
Opioid Claims
$300
Opioid Cost
—
Long-Acting Rate
Brand vs Generic
Brand: 1,336 claims · $910K
Generic: 7,965 claims · $154K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Evolocumab | 127 | $177K |
| Semaglutide | 134 | $132K |
| Empagliflozin | 92 | $75K |
| Tirzepatide | 61 | $69K |
| Dapagliflozin Propanediol | 89 | $66K |
| Dulaglutide | 31 | $42K |
| Apixaban | 57 | $35K |
| Mirabegron | 75 | $32K |
| Fluticasone/Umeclidin/Vilanter | 49 | $31K |
| Alirocumab | 20 | $28K |
| Evolocumab | 16 | $22K |
| Icosapent Ethyl | 68 | $21K |
| Insulin Lispro Protamin/Lispro | 12 | $19K |
| Rivaroxaban | 29 | $17K |
| Pitavastatin Calcium | 38 | $15K |
Prescribing Profile
Patient Profile
74
Avg Age
51%
Female
0.91
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations.Methodology · About